Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir
Science Advances · 24.04.2026 · 12 (17)
DOI: 10.1126/sciadv.aeb7602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.04.2026. Verfasst von Laura Ermellino und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, HIV Infections, Programmed Cell Death 1 Receptor, HIV-1. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gabriella Giorgi-Cavaglieri Foundation, Swiss Vaccine Institute.
Abstract (Originalsprache)
The unique ability of chimeric antigen receptor (CAR) T cells to infiltrate tissues is revolutionizing our perspectives for tackling severe, refractory and otherwise untreatable diseases. In HIV, CAR-T cells have been designed to target viral biomarkers, with limited success so far. Here, we investigated the possibility of redirecting CAR-T cells against a cellular biomarker of the HIV reservoir, the programmed cell death protein 1 (PD-1). We designed two second-generation 4-1BB-CARs using the scFv of either a blocking (bPD1-CAR) or a nonblocking (nbPD1-CAR) anti–PD-1 monoclonal antibody. The CAR avidity modulated T cell sensitivity, trogocytosis, and effector functions, independently of the PD-1 signaling domain. Both anti–PD-1 CAR-T cells could persist for 70 days in HIV-infected humanized mice, correlating with viral protection and a disruption of the lymphoid architecture in the white pulp of the spleen. Together, our results open strategic avenues for reducing the HIV reservoir by demonstrating the feasibility of depleting specific T cell subpopulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
- Bioinformatics Platform, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Laura Ermellino, Spiros Georgakis, Nicole P Kadzioch, Ana Alcaraz-Serna, Oscar Alfageme-Abello, Raphaël Porret, Rebecca Cecchin, Michail Orfanakis, Rachel Schelling, Cloé Brenna, Duy-Cat Can, Mathilde Foglierini, Laurent Perez, Craig Fenwick, Constantinos Petrovas, Roberto F Speck, Giuseppe Pantaleo, Yannick D Muller
Förderung
- Gabriella Giorgi-Cavaglieri Foundation
- Swiss Vaccine Institute
Zitieren
APA
Ermellino, L., Banga, R., Georgakis, S., Kadzioch, N. P., Procopio, F., Alcaraz-Serna, A., Alfageme-Abello, O., Porret, R., Cecchin, R., Orfanakis, M., Schelling, R., Brenna, C., Can, D. C., Foglierini, M., Chén, O. Y., Perez, L., Fenwick, C., Perreau, M., Petrovas, C., …, & Muller, Y. D. (2026). Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir. Science Advances, 12(17). https://doi.org/10.1126/sciadv.aeb7602
Vancouver
Ermellino L, Banga R, Georgakis S, Kadzioch NP, Procopio F, Alcaraz-Serna A, et al. Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir. Science Advances. 2026;12(17). doi:10.1126/sciadv.aeb7602
BibTeX
@article{Ermellino2026,
author = {Ermellino, Laura and Banga, Riddhima and Georgakis, Spiros and Kadzioch, Nicole P and Procopio, Francesco and Alcaraz-Serna, Ana and Alfageme-Abello, Oscar and Porret, Raphaël and Cecchin, Rebecca and Orfanakis, Michail and Schelling, Rachel and Brenna, Cloé and Can, Duy-Cat and Foglierini, Mathilde and Chén, Oliver Y and Perez, Laurent and Fenwick, Craig and Perreau, Matthieu and Petrovas, Constantinos and Speck, Roberto F and Pantaleo, Giuseppe and Muller, Yannick D},
title = {Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {17},
doi = {10.1126/sciadv.aeb7602}
}
EUVIMED